Trial Profile
Vasoprotection by Atorvastatin in Children and Adolescents with Diabetes Type 1, a 2-Year Pilot Study.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 May 2019
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 08 Sep 2011 New trial record